400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / PPAR / Gemfibrozil/吉非罗齐
CAS No.: 25812-30-0
Synonyms: CI-719;Lopid;5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid
Gemfibrozil is an agonist of PPARα. It can act as a hyperlipidemic agent that elevates plasma HDL and lowers triglycerides.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01974544 | Type 2 Diabetes | Not Applicable | Unknown | December 2016 | Chile ... more >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse 56223543527 macastia@uc.cl Contact: Vega Andrea, Nurse 56223543879 abvega@uc.cl Principal Investigator: Boza Camilo, MD surgeon Sub-Investigator: Valderas Juan Patricio, MD Sub-Investigator: Arrese Marco, MD Internist Sub-Investigator: Muñoz Rodrigo, MD Collapse << |
NCT03323788 | - | - | Recruiting | August 1, 2018 | United States, Arizona ... more >> The University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Oscar Parra, MADM 520-626-6485 oscardp@email.arizona.edu Principal Investigator: Lawrence Mandarino, PhD Collapse << |
NCT00004266 | Diabetic Nephropathy | Phase 3 | Completed | - | United States, Minnesota ... more >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Collapse << |
实验方案
技术信息
CAS号 | 25812-30-0 | 储存条件 |
|
|||||
分子式 | C15H22O3 | 运输 | 蓝冰 | |||||
分子量 | 250.33 | 别名 | CI-719;Lopid;5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid;Jezil;Lipur;Trialmin;Pilder;吉非罗齐 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01974544 | Type 2 Diabetes | Not Applicable | Unknown | December 2016 | Chile ... more >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse 56223543527 macastia@uc.cl Contact: Vega Andrea, Nurse 56223543879 abvega@uc.cl Principal Investigator: Boza Camilo, MD surgeon Sub-Investigator: Valderas Juan Patricio, MD Sub-Investigator: Arrese Marco, MD Internist Sub-Investigator: Muñoz Rodrigo, MD Collapse << |
NCT03323788 | - | - | Recruiting | August 1, 2018 | United States, Arizona ... more >> The University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Oscar Parra, MADM 520-626-6485 oscardp@email.arizona.edu Principal Investigator: Lawrence Mandarino, PhD Collapse << |
NCT00004266 | Diabetic Nephropathy | Phase 3 | Completed | - | United States, Minnesota ... more >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Collapse << |
NCT03031821 | Prostate Cancer ... more >> Metabolic Syndrome Collapse << | Phase 3 | Not yet recruiting | June 1, 2023 | Canada, British Columbia ... more >> BC Cancer Agency - Vancouver Cancer Centre Not yet recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Bernie Eigl, MD 604-877-6000 bernie.eigl@bccancer.bc.ca Principal Investigator: Bernie Eigl, MD Collapse << |
NCT03723395 | Drug-drug Interaction | Phase 1 | Recruiting | November 2018 | United States, Florida ... more >> Covance Clinical Research Unit Recruiting Daytona Beach, Florida, United States, 32117 Contact: Michelle Saint Pierre 386-366-6428 michelle.saintpierre@covance.com Principal Investigator: Hugh Coleman United States, Texas Covance Clinical Research Unit Recruiting Dallas, Texas, United States, 75247 Contact: Iona Tihina 469-513-6716 Ioana.Tihina@covance.com Principal Investigator: Jennifer Zon Collapse << |
NCT01148004 | HIV Fenofibra... more >>te Protease Inhibitors Hypertriglyceridemia Glucuronosyltransferase Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT00000461 | Cardiovascular Diseases ... more >> Coronary Disease Heart Diseases Myocardial Ischemia Collapse << | Phase 2 | Completed | - | - |
NCT00005676 | - | - | Completed | - | - |
NCT00243672 | Atherosclerosis | Phase 4 | Withdrawn(The study chair chan... more >>ged his employment, the realization of the study was not possible) Collapse << | - | - |
NCT03624959 | Healthy Volunteer | Phase 1 | Recruiting | April 15, 2019 | United States, Texas ... more >> PPD Phase 1 Clinic Recruiting Austin, Texas, United States, 78744 Collapse << |
NCT00039663 | HIV Infections | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States, 20892 Collapse << |
NCT00283335 | Coronary Heart Disease | Phase 3 | Completed | - | United States, Minnesota ... more >> Minneapolis VA Health Care System, Minneapolis, MN Minneapolis, Minnesota, United States, 55417 Collapse << |
NCT00108511 | Hypertriglyceridemia | Phase 1 | Completed | - | United States, Indiana ... more >> Roudebush VA Medical Center Indianapolis, Indiana, United States, 46202 Collapse << |
NCT01836198 | Healthy Volunteers | Phase 1 | Completed | - | United States, Indiana ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47710 Collapse << |
NCT01913379 | Healthy Subjects ... more >> Pharmacokinetics Drug-Drug Interaction Collapse << | Phase 1 | Completed | - | France ... more >> SGS Paris, France, 75015 Collapse << |
NCT01797198 | Drug-Drug Interaction (DDI) ... more >> Healthy Subjects Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> PAREXEL Early Phase Clinical Unit Harrow, United Kingdom, HA1 3U Collapse << |
NCT01301742 | Healthy | Phase 1 | Completed | - | Germany ... more >> 1245.58.1 Boehringer Ingelheim Investigational Site Biberach, Germany Collapse << |
NCT01340846 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, Florida GSK Investigational Site Sarasota, Florida, United States, 34232 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 United Kingdom GSK Investigational Site Headington, United Kingdom, OX3 7LJ GSK Investigational Site London, United Kingdom, W1G 6AD Collapse << |
NCT01376232 | Anaemia | Phase 1 | Completed | - | India ... more >> GSK Investigational Site Electronics City, Bengalore, India, 560100 Collapse << |
NCT01301742 | - | - | Completed | - | - |
NCT02230033 | Healthy | Phase 1 | Completed | - | United States, Arizona ... more >> Tempe, Arizona, United States Collapse << |
NCT01736254 | Healthy Volunteers | Phase 1 | Completed | - | United States, Florida ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 Collapse << |
NCT00800475 | Bioavailability | Phase 1 | Completed | - | - |
NCT02770222 | Healthy Subjects | Phase 1 | Completed | - | Germany ... more >> Investigator Site Kiel, Germany, 24105 Collapse << |
NCT00566865 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT00966966 | Healthy | Phase 1 | Completed | - | Netherlands ... more >> Pfizer Investigational Site Utrecht, Netherlands, 3584 CJ Collapse << |
NCT02045056 | Preclinical Alzheimer's Diseas... more >>e Collapse << | Early Phase 1 | Active, not recruiting | June 2019 | United States, Kentucky ... more >> University of Kentucky Lexington, Kentucky, United States, 40536-0230 Collapse << |
NCT00474201 | Healthy Volunteers | Not Applicable | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT01876810 | Nicotine Dependence | Phase 2 | Completed | - | Canada, Ontario ... more >> Centre for Addiction and Mental Health Toronto, Ontario, Canada, M5S 1S8 Centre of Addiction and Mental Health Toronto, Ontario, Canada, M5S 2S1 Collapse << |
NCT01736254 | - | - | Completed | - | - |
NCT03539432 | Alcohol Use Disorder | Phase 2 | Active, not recruiting | December 30, 2018 | United States, New Mexico ... more >> The Mind Research Network Albuquerque, New Mexico, United States, 87106 Collapse << |
NCT01385020 | Healthy Subjects | Phase 4 | Completed | - | Taiwan ... more >> National Taiwan University Hospital Taipei, Taiwan Collapse << |
NCT01083212 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Sweden ... more >> Reserach Site Linkoping, Sweden Research Site Lulea, Sweden Research Site Uppsala, Sweden Collapse << |
NCT00474201 | - | - | Completed | - | - |
NCT01876810 | - | - | Completed | - | - |
NCT02638597 | Smoking Cessation | Phase 2 | Unknown | March 2017 | United States, Texas ... more >> Parkland Memorial Hospital Recruiting Dallas, Texas, United States, 75235 Contact: Adriane Dela Cruz 214-648-7312 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网